Iconic Labs plcLSE: ICON

Iconic Labs: Total Voting Rights & Admission to Trading

· Issued by Iconic Labs PLC via RNS

Summary by 6ix AI

Iconic Labs PLC said that as at October 30, 2026, its issued share capital consists of 18,415,202 ordinary shares of £0.0001 each, each with one voting right, and it holds no shares in treasury (shares a company has bought back and keeps), so total voting rights are 18,415,202.

Key details

  • 370,370 new ordinary shares were admitted to trading on the Main Market of the London Stock Exchange on October 5, 2026, and 416,667 on October 30, 2026, a total of 787,037 further shares issued and admitted; they are fully fungible (interchangeable) with the existing ordinary shares.
  • Shareholders should use 18,415,202 as the total number of voting rights when calculating whether they are required to notify their interest in, or a change to their interest in, the company's share capital under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/total-voting-rights-and-admission-to-trading-8

Iconic Labs PLC
30 October 2026
 

Iconic Labs PLC

("Iconic" or the "Company")

Total Voting Rights & Admission to Trading

Total Voting Rights

In accordance with the FCA's Disclosure Guidance and Transparency Rules, as at 30 October 2026, the Company's issued share capital consists of 18,415,202 Ordinary Shares of £0.0001, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 18,415,202.

The above figure of 18,415,202 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Admission to Trading

In accordance with the Financial Conduct Authority’s Prospectus Rules, Iconic announces that 370,370 new Ordinary Shares in the Company were admitted to trading on the Main Market of the London Stock Exchange on 5 October 2026 and 416,667 new Ordinary Shares in the Company were admitted to trading on the Main Market of the London Stock Exchange on 30 October 2026.

1)

Name and LEI

Iconic Labs PLC

213800YCXZV6RSHGGT04

2)

Regulated Market

London Stock Exchange – Main Market

3)

Name, type and ISIN

Ordinary Shares of £0.0001 each

ISIN: GB00BRBJ3P08

4)

Number of further securities issued and admitted

787,037

5)

Total number of securities in issue following admission

18,415,202

6)

Fungibility

Fully fungible with existing Ordinary Shares

7)

Dates of Admission

5 October 2026 and 30 October 2026

8)

Prospectus Information

N/A

--ENDS--

For any further information or enquiries please contact:

Iconic Labs

John Farquharson, Chief Executive Officer

via Yellow Jersey PR

AlbR Capital Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7469 0930

Yellow Jersey PR

Charles Goodwin

Tel: +44 (0) 20 3004 9512

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Iconic Labs plc on 6ix

Story so far

Earlier from Iconic Labs

All Iconic Labs news releases